Search Results 31-40 of 17595 for Prednisone

1. Corticosteroid (Oral Route, Parenteral Route) Before Using - Mayo Clinic

   Older patients may be more likely to develop high blood pressure or osteoporosis (bone disease) from corticosteroids. Women are especially at risk of developing ...

2. A Study of Treatment with Docetaxel and Prednisone, with or without Vaccine Therapy, for Patients who have Metastatic Hormone-Resistant Prostate Cancer - Mayo Clinic

   Vaccines made from an antigen may help the body build an effective immune response to kill tumor cells. It is not yet known whether docetaxel and prednisone are ...

3. Corticosteroid (Oral Route, Parenteral Route) Proper Use - Mayo Clinic

   For prednisone. For oral dosage forms (oral solution, syrup, tablets):. Adults and teenagers—5 to 200 milligrams (mg) every one or two days, as a single dose ...

4. Methylprednisolone (Oral Route) Proper Use - Mayo Clinic

   However, if it is almost time for your next dose, skip the missed dose and go back to your regular dosing schedule. Do not double doses. Storage. Store the ...

5. Methylprednisolone (Injection Route) Side Effects - Mayo Clinic

   Backache · bloody, black, or tarry stools · chills · dark urine · darkening of the skin · decrease in height · decreased vision · diarrhea ...

6. Abiraterone (Oral Route) Proper Use - Mayo Clinic

   Dosing · Adults—1000 milligrams (mg) (two 500 mg tablets or four 250 mg tablets) once a day, taken together with 5 mg oral prednisone 2 times a day. · Children— ...

7. Methylprednisolone (Oral Route) Side Effects - Mayo Clinic

   Incidence not known · Black, tarry stools · blindness · bloating · bloody vomit · blurred vision · bone pain · change in vision · chest pain or tightness ...

8. Abiraterone/Prednisone, Olaparib, or Abiraterone/Prednisone + Olaparib in Patients With Metastatic Castration-Resistant Prostate Cancer With DNA Repair Defects - Mayo Clinic

   Abiraterone/Prednisone, Olaparib, or Abiraterone/Prednisone + Olaparib in Patients With Metastatic Castration-Resistant Prostate Cancer With DNA Repair Defects.

9. Enzalutamide With or Without Abiraterone and Prednisone in Treating Patients With Castration-Resistant Metastatic Prostate Cancer - Mayo Clinic

   Androgens can cause the growth of prostate cancer cells. Drugs, such as enzalutamide, abiraterone acetate, and prednisone, may lessen the amount of androgens ...

10. A Study Comparing Orteronel Plus Prednisone in Patients with Metastatic Castration-Resistant Prostate Cancer, who have not had Chemotherapy - Mayo Clinic

    The purpose of this study is to evaluate orteronel (TAK-700) combined with prednisone, compared to a placebo and prednisone, for the treatment of men with ...